MAIT cells: new guardians of the liver

Clinical and Translational Immunology

Volumn 5, Issue 8, 2016, Pages

  Kurioka, Ayako ^a   Walker, Lucy J ^b   Klenerman, Paul ^a,c   Willberg, Christian B ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85136824254     PISSN: None     EISSN: 20500068     Source Type: Journal    
DOI: 10.1038/CTI.2016.51     Document Type: Review

References (112)

1. Balmer ML, Slack E, de Gottardi A, Lawson MAE, Hapfelmeier S, Miele L et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci Transl Med 2014; 6: 237ra66.
2. Dusseaux M, Martin E, Serriari N, Péguillet I, Premel V, Louis D et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 2011; 117: 1250–1259.
3. Kenna T, Golden-Mason L, Porcelli SA, Koezuka Y, Hegarty JE, O’Farrelly C et al. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells. J Immunol 2003; 171: 1775–1779.
4. Rajoriya N, Fergusson JR, Leithead JA, Klenerman P. Gamma delta T-lymphocytes in hepatitis C and chronic liver disease. Front Immunol 2014; 5: 400.
5. − alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. JExp Med 1993; 178: 1–16.
6. Tilloy F, Treiner E, Park SH, Garcia C, Lemonnier F, de la Salle H et al. An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J Exp Med 1999; 189: 1907–1921.
7. Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 2003; 422: 164–169.
8. Le Bourhis L, Martin E, Péguillet I, Guihot A, Froux N, Coré M et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 2010; 11: 701–708.
9. Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, Delepine J et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 2010; 8: e1000407.
10. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 2012; 491: 717–723.
11. Jo J, Tan AT, Ussher JE, Sandalova E, Tang X-Z, Tan-Garcia A et al. Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver. PLoS Pathog 2014; 10: e1004210.
12. Hashimoto K, Hirai M, Kurosawa Y. A gene outside the human MHC related to classical HLA class I genes. Science (80-) 1995; 269: 693–695.
13. Riegert P, Wanner V, Bahram S. Genomics, isoforms, expression, and phylogeny of the MHC class I-related MR1 gene. JImmunol 1998; 161: 4066–4077.
14. Tsukamoto K, Deakin JE, Graves JAM, Hashimoto K. Exceptionally high conservation of the MHC class I-related gene, MR1, among mammals. Immunogenetics 2013; 65: 115–124.
15. Yamaguchi H, Kurosawa Y, Hashimoto K. Expanded genomic organization of conserved mammalian MHC class I-related genes, human MR1 and its murine ortholog. Biochem Biophys Res Commun 1998; 250: 558–564.
16. Corbett AJ, Eckle SBG, Birkinshaw RW, Liu L, Patel O, Mahony J et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 2014; 509: 361–365.
17. Eckle SBG, Birkinshaw RW, Kostenko L, Corbett AJ, McWilliam HEG, Reantragoon R et al. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells. J Exp Med 2014; 211: 1585–1600.
18. Soudais C, Samassa F, Sarkis M, Le Bourhis L, Bessoles S, Blanot D et al. In vitro and in vivo analysis of the Gram-negative bacteria-derived riboflavin precursor derivatives activating mouse MAIT cells. JImmunol2015; 194: 4641–4649.
19. Gherardin NA, Keller AN, Woolley RE, Le Nours J, Ritchie DS, Neeson PJ et al. Diversity of T cells restricted by the MHC class I-related molecule MR1 facilitates differential antigen recognition. Immunity 2016; 44: 32–45.
20. Reantragoon R, Corbett AJ, Sakala IG, Gherardin NA, Furness JB, Chen Z et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med 2013; 210: 2305–2320.
21. Rahimpour A, Koay HF, Enders A, Clanchy R, Eckle SBG, Meehan B et al. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J Exp Med 2015; 212: 1095–1108.
22. Huang S, Gilfillan S, Cella M, Miley MJ, Lantz O, Lybarger L et al. Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. JBiolChem2005; 280: 21183–21193.
23. Chua W-J, Kim S, Myers N, Huang S, Yu L, Fremont DH et al. Endogenous MHC-related protein 1 is transiently expressed on the plasma membrane in a conformation that activates mucosal-associated invariant T cells. J Immunol 2011; 186: 4744–4750.
24. McWilliam HEG, Eckle SBG, Theodossis A, Liu L, Chen Z, Wubben JM et al. The intracellular pathway for the presentation of vitamin B-related antigens by the antigen-presenting molecule MR1. Nat Immunol 2016; 5: 531–517.
25. Harriff MJ, Karamooz E, Burr A, Grant WF, Canfield ET, Sorensen ML et al. Endosomal MR1 trafficking plays a key role in presentation of mycobacterium tuberculosis ligands to MAIT cells. PLoS Pathog 2016; 12: e1005524.
26. Ussher JE, van Wilgenburg B, Hannaway RF, Ruustal K, Phalora P, Kurioka A et al. TLR signalling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells. Eur J Immunol 2016; 46: 1600–1614.
27. López-Sagaseta J, Dulberger CL, Crooks JE, Parks CD, Luoma AM, McFedries A et al. The molecular basis for mucosal-associated invariant T cell recognition of MR1 proteins. Proc Natl Acad Sci USA 2013; 110: E1771–E1778.
28. Lepore M, Kalinichenko A, Kalinicenko A, Colone A, Paleja B, Singhal A et al. Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire. Nat Commun 2014; 5: 3866.
29. Sakala IG, Kjer-Nielsen L, Eickhoff CS, Wang X, Blazevic A, Liu L et al. Functional heterogeneity and antimycobacterial effects of mouse mucosal-associated invariant T cells specific for riboflavin metabolites. J Immunol 2015; 195: 587–601.
30. Leeansyah E, Loh L, Nixon DF, Sandberg JK. Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development. Nat Commun 2014; 5: 3143.
31. + Tcellsdefines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci USA 2010; 107: 3006–3011.
32. Serriari N-E, Eoche M, Lamotte L, Lion J, Fumery M, Marcelo P et al. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol 2014; 176: 266–274.
33. ++/MAIT cells in HIV infection. Blood 2013; 121: 951–961.
34. + T cells enriched within the gut. Mucosal Immunol 2015; 9: 401–413.
35. Leeansyah E, Ganesh A, Quigley MF, Sönnerborg A, Andersson J, Hunt PW et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 2013; 121: 1124–1135.
36. Tang X, Jo J, Tan AT, Sandalova E, Chia A, Tan KC et al. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. JImmunol2013; 190: 3142–3152.
37. Jeffery HC, van Wilgenburg B, Kurioka A, Parekh K, Stirling K, Roberts S et al. Bacteria exposed biliary epithelium and liver B cells activate intrahepatic MAIT cells in an MR1-dependent manner. JHepatol 2016; 64: 1118–1127.
38. Hinks TSC, Wallington JC, Williams AP, Djukanović R, Staples KJ, Wilkinson TMA. Steroid-induced deficiency of mucosal-associated invariant T cells in the COPD lung: implications for NTHi infection. Am J Respir Crit Care Med (e-pub ahead of print 26 April 2016; doi:10.1164/rccm.201601-0002OC).
39. Gibbs A, Leeansyah E, Introini A, Paquin-Proulx D, Hasselrot K, Andersson E et al. MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulation. Mucosal Immunol (e-pub ahead of print 6 April 2016; doi:10.1038/mi.2016.30).
40. Kawachi I, Maldonado J, Strader C, Gilfillan S. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. JImmunol2006; 176: 1618–1627.
41. Cui Y, Franciszkiewicz K, Mburu YK, Mondot S, Le Bourhis L, Premel V et al. Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation. J Clin Invest 2015; 125: 4171–4185.
42. Meierovics A, Yankelevich WC, Cowley SC. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci USA 2013; 110: E3119–E3128.
43. Chen Z, Wang H, D’Souza C, Sun S, Kostenko L, Eckle SBG et al. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Mucosal Immunol (e-pub ahead of print 4 May 2016; doi:10.1038/mi.2016.39).
44. + T cells. Blood 2012; 119: 422–433.
45. Magalhaes I, Pingris K, Poitou C, Bessoles S, Venteclef N, Kiaf B et al. Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest 2015; 125: 1752–1762.
46. Martin E, Treiner E, Duban L, Guerri L, Laude H, Toly C et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol 2009; 7: e1000054.
47. +IL-18 in a TCR-independent manner. Eur J Immunol 2014; 44: 195–203.
48. Chua W-J, Truscott SM, Eickhoff CS, Blazevic A, Hoft DF, Hansen TH. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect Immun 2012; 80: 3256–3267.
49. +, and CD4-CD8-T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18. Jimmunol 1998; 160: 3759–3765.
50. Brigl M, Tatituri RVV, Watts GFM, Bhowruth V, Leadbetter EA, Barton N et al. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J Exp Med 2011; 208: 1163–1177.
51. Savage AK, Constantinides MG, Han J, Picard D, Martin E, Li B et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 2008; 29: 391–403.
52. Miyazaki Y, Miyake S, Chiba A, Lantz O, Yamamura T. Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol 2011; 23: 529–535.
53. Cho Y-N, Kee S-J, Kim T-J, Jin HM, Kim M-J, Jung H-J et al. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. J Immunol 2014; 193: 3891–3901.
54. Carolan E, Tobin LM, Mangan BA, Corrigan M, Gaoatswe G, Byrne G et al. Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity. JImmunol2015; 194: 5775–5780.
55. Martin E, Bourhis LL, Dusseaux M, Bohineust A, Sleurs D, Serriari N et al. MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. Plos Pathog 2013; 9: e1003681.
56. Kurioka A, Ussher JE, Cosgrove C, Clough C, Fergusson JR, Smith K et al. MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol 2015; 8: 429–440.
57. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley MF et al. Arming of MAIT cell cytolytic antimicrobial activity is induced by IL-7 and defective in HIV-1 infection. PLoS Pathog 2015; 11: e1005072.
58. Sattler A, Dang-Heine C, Reinke P, Babel N. IL-15 dependent induction of IL-18 secretion as a feedback mechanism controlling human MAIT-cell effector functions. Eur J Immunol 2015; 45: 2286–2298.
59. Dias J, Sobkowiak MJ, Sandberg JK, Leeansyah E. Human MAIT-cell responses to Escherichia coli: activation, cytokine production, proliferation, and cytotoxicity. JLeukocBiol2016; 100: 233–240.
60. Gérart S, Sibéril S, Martin E, Lenoir C, Aguilar C, Lantz O et al. Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP. Blood 2013; 121: 614–623.
61. Georgel P, Radosavljevic M, Macquin C, Bahram S. The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Mol Immunol 2011; 48: 769–775.
62. Jiang J, Wang X, An H, Yang B, Cao Z, Liu Y et al. Mucosal-associated invariant T-cell function is modulated by programmed death-1 signaling in patients with active tuberculosis. Am J Respir Crit Care Med 2014; 190: 329–339.
63. ++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression. PLoS ONE 2015; 10: e0124659.
64. Leung DT, Bhuiyan TR, Nishat NS, Hoq MR, Aktar A, Rahman MA et al. Circulating mucosal associated invariant T cells are activated in vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses. Vinetz JM, editor. PLoS Negl Trop Dis 2014; 8: e3076.
65. Smith DJ, Hill GR, Bell SC, Reid DW. Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis. PLoS ONE 2014; 9: e109891.
66. Grimaldi D, Le Bourhis L, Sauneuf B, Dechartres A, Rousseau C, Ouaaz F et al. Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intens Care Med 2014; 40: 192–201.
67. Fernandez CS, Amarasena T, Kelleher AD, Rossjohn J, McCluskey J, Godfrey DI et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol 2015; 93: 177–188.
68. + T-cell immune activation. AIDS 2014; 28: 1690–1692.
69. + MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression. PLoS ONE 2014; 9: e111323.
70. + mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS ONE 2013; 8: e83474.
71. Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, Winter SE et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008; 14: 421–428.
72. van Wilgenburg B, Scherwitzl I, Hutchinson EC, Leng T, Kurioka A, Kulicke C et al. MAIT cells are activated during human viral infections. Nat Commun 2016; 7: 11653.
73. Hengst J, Strunz B, Deterding K, Ljunggren H-G, Leeansyah E, Manns MP et al. Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy. Eur J Immunol (e-pub ahead of print 14 June 2016; doi:10.1002/eji.201646447).
74. Hinks TSC. Mucosal-associated invariant T cells in autoimmunity, immune-mediated diseases and airways disease. Immunology 2016; 148: 1–12.
75. Hiejima E, Kawai T, Nakase H, Tsuruyama T, Morimoto T, Yasumi T et al. Reduced numbers and proapoptotic features of mucosal-associated invariant t cells as a characteristic finding in patients with inflammatory bowel disease. Inflamm Bowel Dis 2015; 21: 1529–1540.
76. Haga K, Chiba A, Shibuya T, Osada T, Ishikawa D, Kodani T et al. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis. JGastro-enterol Hepatol 2015; 5: 965–972.
77. Salou M, Nicol B, Garcia A, Baron D, Michel L, Ngono AE et al. Neuropathologic, phenotypic and functional analyses of mucosal associated invariant T cells in multiple sclerosis. Clin Immunol 2016; 166-167: 1–11.
78. Dunne MR, Elliott L, Hussey S, Mahmud N, Kelly J, Doherty DG et al. Persistent changes in circulating and intestinal γδ T cell subsets, invariant natural killer T cells and mucosal-associated invariant T cells in children and adults with coeliac disease. PLoS ONE 2013; 8: e76008.
79. Chiba A, Tajima R, Tomi C, Miyazaki Y, Yamamura T, Miyake S. Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis. Arthritis Rheum 2012; 64: 153–161.
80. +T cells bear pathogenetic potential in multiple sclerosis. Brain 2011; 134: 542–554.
81. +) MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis. Eur J Immunol 2014; 44: 3119–3128.
82. Croxford JL, Miyake S, Huang Y-Y, Shimamura M, Yamamura T. Invariant V(alpha)19i T cells regulate autoimmune inflammation. Nat Immunol 2006; 7: 987–994.
83. Peterfalvi A, Gomori E, Magyarlaki T, Pal J, Banati M, Javorhazy A et al. Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells. Int Immunol 2008; 20: 1517–1525.
84. Sundström P, Ahlmanner F, Akéus P, Sundquist M, Alsén S, Yrlid U et al. Human mucosa-associated invariant T cells accumulate in colon adenocarcinomas but produce reduced amounts of IFN-γ. J Immunol 2015; 195: 3472–3481.
85. Ling L, Lin Y, Zheng W, Hong S, Tang X, Zhao P et al. Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients. Sci Rep 2016; 6: 20358.
86. Zabijak L, Attencourt C, Guignant C, Chatelain D, Marcelo P, Marolleau J-P et al. Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients. Cancer Immunol Immunother 2015; 64: 1601–1608.
87. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012; 491: 254–258.
88. Wu P, Wu D, Ni C, Ye J, Chen W, Hu G et al. γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 2014; 40: 785–800.
89. Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau C-S et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 2015; 522: 345–348.
90. Nieda M, Okai M, Tazbirkova A, Lin H, Yamaura A, Ide K et al. Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 2004; 103: 383–389.
91. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004; 303: 1662–1665.
92. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006; 26: 1175–1186.
93. Hieshima K, Imai T, Opdenakker G, Van Damme J, Kusuda J, Tei H et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. JBiolChem1997; 272: 5846–5853.
94. Wilbanks A, Zondlo SC, Murphy K, Mak S, Soler D, Langdon P et al. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. JImmunol2001; 166: 5145–5154.
95. + NKT cells patrolling liver sinusoids. PLoS Biol 2005; 3: e113.
96. Oo YH, Banz V, Kavanagh D, Liaskou E, Withers DR, Humphreys E et al. CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver. JHepatol2012; 57: 1044–1051.
97. Adams DH, Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol 2006; 6: 244–251.
98. Cervantes JL, Dunham-Ems SM, La Vake CJ, Petzke MM, Sahay B, Sellati TJ et al. Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta. Proc Natl Acad Sci USA 2011; 108: 3683–3688.
99. Harada K, Shimoda S, Sato Y, Isse K, Ikeda H, Nakanuma Y. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol 2009; 157: 261–270.
100. Shaw MH, Kamada N, Kim Y-G, Núñez G. Microbiota-induced IL-1β, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J Exp Med 2012; 209: 251–258.
101. Afford SC, Ahmed-Choudhury J, Randhawa S, Russell C, Youster J, Crosby HA et al. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells. FASEB J 2001; 15: 2345–2354.
102. Satapathy SK, Sanyal AJ. Epidemiology and natural history of nonalcoholic fatty liver disease. Semin Liver Dis 2015; 35: 221–235.
103. Sayiner M, Koenig A, Henry L, Younossi ZM. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world. Clin Liver Dis 2016; 20: 205–214.
104. Liu W, Baker RD, Bhatia T, Zhu L, Baker SS. Pathogenesis of nonalcoholic steatohepatitis. Cell Mol Life Sci 2016; 73: 1969–1987.
105. Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard SM. Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 2007; 293: E656–E665.
106. Shimamura M, Huang Y-Y, Goji H, Endo S, Migishima R, Yokoyama M. Regulation of immunological disorders by invariant Vα19-Jα33 TCR-bearing cells. Immunobiology 2011; 216: 374–378.
107. Illés Z, Shimamura M, Newcombe J, Oka N, Yamamura T. Accumulation of Valpha7.2-Jalpha33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int Immunol 2004; 16: 223–230.
108. + mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics. PLoS ONE 2015; 10: e0117335.
109. +T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. J Invest Dermatol 2014; 134: 2898–2907.
110. Li J, Reantragoon R, Kostenko L, Corbett AJ, Varigos G, Carbone FR. The frequency of mucosal-associated invariant T cells is selectively increased in dermatitis herpetiformis. Australas J Dermatol (e-pub ahead of print 4 March 2016; doi:10.1111/ajd.12456).
111. Hinks TSC, Zhou X, Staples KJ, Dimitrov BD, Manta A, Petrossian T et al. Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms. J Allergy Clin Immunol 2015; 136: 323–333.
112. Kim J-C, Jin H-M, Cho Y-N, Kwon Y-S, Kee S-J, Park Y-W. Deficiencies of circulating mucosal-associated invariant T cells and natural killer T cells in patients with acute cholecystitis. JKoreanMedSci2015; 30: 606–611.